A study to compare Onivyde manufactured at two different production sites in adult participants with advanced cancer in the pancreas

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516760-28-00

Acronym

D-FR-60010-015

Enrollment

120

Registered

2024-10-14

Start date

2022-05-04

Completion date

2025-04-15

Last updated

2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Pancreatic Adenocarcinoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Hungary, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026